Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts Newmont to Delist from Toronto Stock Exchange as Cost Cuts Deepen September 15, 2025 Completion of Non-Renounceable Pro-Rata Entitlement Offer September 15, 2025 Significant Enlargement of Exploration Program September 15, 2025